StonvexLoading…
StonvexStonvexStonvexCore line items from NBIS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 |
|---|---|---|---|---|
Revenue | $1.31B | $752.60M | $272.70M | $2.22B |
Operating Income | $-158.00M | $-178.70M | $220.00M | $313.30M |
Net Income | $745.60M | $-197.20M | $24.71B | $11.06B |
EPS (Diluted) | $1.59 | $-0.54 | $0.98 | $0.48 |
Total Assets | $8.77B | $6.94B | $6.98B | $3.69B |
Total Liabilities | $3.96B | $3.27B | $2.25B | $782.40M |
Cash & Equivalents | $288.50M | $1.13B | $1.78B | $763.60M |
Free Cash Flow OCF − CapEx | $682.40M | $-475.50M | $109.00M | $302.30M |
Shares Outstanding | 368.02M | 362.39M | 353.38M | 335.43M |